Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

NCT ID: NCT01868516

Last Updated: 2015-06-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

1635 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-05-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Overactive bladder (OAB) is a syndrome characterized by symptoms of a sudden need to urinate with or without incontinence (leaking). The purpose of this study is to test whether dexmecamylamine is safe and effective compared to placebo for the treatment of symptoms of OAB.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The study included a three- or five-week screening period, followed by a 12-week treatment period during which patients received either one of three doses of dexmecamylamine or placebo twice daily, randomized in a ratio of 2:1:1:1 (placebo, low dose, mid dose, high dose), with a two-week follow-up period. A total of 768 subjects with overactive bladder were randomized into the double-blind treatment period of the study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Overactive Bladder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Placebo

One tablet of placebo to be administered orally twice a day.

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DRUG

0.5 mg dexmecamylamine (TC-5214)

One tablet of 0.5 mg dexmecamylamine to be administered orally twice a day.

Group Type EXPERIMENTAL

dexmecamylamine

Intervention Type DRUG

1 mg dexmecamylamine (TC-5214)

One tablet of 1 mg dexmecamylamine to be administered orally twice a day.

Group Type EXPERIMENTAL

dexmecamylamine

Intervention Type DRUG

2 mg dexmecamylamine (TC-5214)

One tablet of 2 mg dexmecamylamine to be administered orally twice a day.

Group Type EXPERIMENTAL

dexmecamylamine

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

dexmecamylamine

Intervention Type DRUG

Placebo

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

TC-5214

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Verified medical history of overactive bladder for at least 6 months
* Capable of walking unassisted to use the bathroom
* Able to measure voided urine volume and complete the diary without assistance
* If the subject is currently being treated with an OAB medication, the subject is willing to discontinue OAB medications while participating in this study

Exclusion Criteria

* Diagnosis of a neurological disease affecting bladder function
* Stress incontinence, insensate incontinence, overflow incontinence or incontinence due to urinary fistula
* History of incomplete bladder emptying, bladder outflow obstruction or post-void residual bladder volume \> 150 mL
* Males with benign prostatic hyperplasia or with a prostate-specific antigen (PSA) of 4 ng/mL or more
* Other urinary tract pathology such as malignancy, ureteric reflux, bladder stone, uninvestigated hematuria, urethral stricture, or cystitis
* Prior treatment with intravesical or intraprostatic botulinum toxin in the last 2 years
* Myasthenia gravis
* Angle closure glaucoma
* Current implantation of interstim electrodes or vaginal surgical mesh
* Presence of a clinically significant medical condition at any time during the study
* Presence of clinically significant abnormalities in laboratory findings, physical exam findings or vital signs
* Participated in an investigational drug trial within 3 months of screening
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Targacept Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Simon-Williamson Clinic, P.C.

Birmingham, Alabama, United States

Site Status

Physician's Resource Group

Dothan, Alabama, United States

Site Status

Coastal Clinical Research, Inc.

Mobile, Alabama, United States

Site Status

Coastal Clinical Research, Inc

Mobile, Alabama, United States

Site Status

Mobile Ob-Gyn, P.C.

Mobile, Alabama, United States

Site Status

Radiant Research, Inc.

Chandler, Arizona, United States

Site Status

Clinical Trials of Arizona, Inc.

Glendale, Arizona, United States

Site Status

Beach Clinical Studies

Phoenix, Arizona, United States

Site Status

Radiant Research, Inc.

Scottsdale, Arizona, United States

Site Status

Genova Clinical Research, Inc.

Tucson, Arizona, United States

Site Status

Radiant Research, Inc.

Tucson, Arizona, United States

Site Status

Lynn Institute of the Ozarks

Little Rock, Arkansas, United States

Site Status

Atlantic Urology Medical Group

Long Beach, California, United States

Site Status

Adam D. Karnes, MD

Los Angeles, California, United States

Site Status

Tri Valley Urology Medical Group

Murrieta, California, United States

Site Status

Center for Clinical Trials, LLC

Paramount, California, United States

Site Status

Northern California Research

Sacramento, California, United States

Site Status

San Diego Sexual Medicine

San Diego, California, United States

Site Status

Genesis Research

San Diego, California, United States

Site Status

Westlake Medical Research

Thousand Oaks, California, United States

Site Status

InFocus Clinical Research

Denver, Colorado, United States

Site Status

Horizons Clinical Research Center, LLC

Denver, Colorado, United States

Site Status

Women's Health Specialty Care

Farmington, Connecticut, United States

Site Status

Connecticut Clinical Research Center, LLC

Middlebury, Connecticut, United States

Site Status

South Florida Medical Research

Aventura, Florida, United States

Site Status

Meridien Reseach

Brooksville, Florida, United States

Site Status

Tampa Bay Medical Research

Clearwater, Florida, United States

Site Status

3H Clinical Research Corporation

Coral Springs, Florida, United States

Site Status

Palm Spring Research Institute

Hialeah, Florida, United States

Site Status

American Medical Research Institute

Kissimmee, Florida, United States

Site Status

Altus Research

Lake Worth, Florida, United States

Site Status

Sunrise Medical Research

Lauderdale Lakes, Florida, United States

Site Status

Suncoast Clinical Research, Inc.

New Port Richey, Florida, United States

Site Status

Advanced Research Institute, Inc.

New Port Richey, Florida, United States

Site Status

Clinical Research of Central Florida

Plant City, Florida, United States

Site Status

Lakeview Medical Research

Summerfield, Florida, United States

Site Status

Southeastern Research Group, Inc.

Tallahassee, Florida, United States

Site Status

Palm Beach Research Center

West Palm Beach, Florida, United States

Site Status

Clinical Research of Central Florida

Winter Haven, Florida, United States

Site Status

Atlanta Medical Research Institute

Alpharetta, Georgia, United States

Site Status

Radiant Reseach, Inc.

Atlanta, Georgia, United States

Site Status

Southeast Regional Research Group

Columbus, Georgia, United States

Site Status

Perimeter North Medical Research, Inc.

Roswell, Georgia, United States

Site Status

Fellows Research Alliance, Inc.

Savannah, Georgia, United States

Site Status

North Georgia Clinical Research

Woodstock, Georgia, United States

Site Status

North Idaho Urology

Coeur d'Alene, Idaho, United States

Site Status

Radiant Research, Inc.

Chicago, Illinois, United States

Site Status

Clinical Investigation Specialists, Inc.

Gurnee, Illinois, United States

Site Status

First Urology PSC

Jeffersonville, Indiana, United States

Site Status

Deaconess Clinic Gateway Health Center

Newburgh, Indiana, United States

Site Status

Heartland Research Associates, LLC

Augusta, Kansas, United States

Site Status

Heartland Research Associates, LLC

Newton, Kansas, United States

Site Status

GTC Research

Shawnee, Kansas, United States

Site Status

Heartland Research Associates, LLC

Wichita, Kansas, United States

Site Status

Bluegrass Clinical Research

Louisville, Kentucky, United States

Site Status

Research Integrity, LLC

Owensboro, Kentucky, United States

Site Status

Regional Urology, LLC

Shreveport, Louisiana, United States

Site Status

Willis-Knighton Physician Network

Shreveport, Louisiana, United States

Site Status

Mid Atlantic Urology Associates, LLC

Greenbelt, Maryland, United States

Site Status

Boston Clinical Trials, Inc.

Boston, Massachusetts, United States

Site Status

Beacon Clinical Research, LLC

Brockton, Massachusetts, United States

Site Status

Bay State Clinical Trials, Inc.

Watertown, Massachusetts, United States

Site Status

Family Medicine Specialists, PC

Grand Rapids, Michigan, United States

Site Status

Beyer Research

Kalamazoo, Michigan, United States

Site Status

Westside Family Medical Center, PC

Kalamazoo, Michigan, United States

Site Status

William Beaumont Hospital

Royal Oak, Michigan, United States

Site Status

Saginaw Valley Medical Reseach Group, LLC

Saginaw, Michigan, United States

Site Status

Radiant Research, Inc.

Edina, Minnesota, United States

Site Status

Metro Urology

Woodbury, Minnesota, United States

Site Status

Mississippi Medical Research, LLC

Carriere, Mississippi, United States

Site Status

Center for Pharmaceutical Research

Kansas City, Missouri, United States

Site Status

Radiant Research, Inc.

St Louis, Missouri, United States

Site Status

Montana Health Research Institute, Inc.

Billings, Montana, United States

Site Status

Five Valleys Urology

Missoula, Montana, United States

Site Status

Women's Clinical of Lincoln, P.C.

Lincoln, Nebraska, United States

Site Status

Quality Clinical Research, Inc.

Omaha, Nebraska, United States

Site Status

Summit Medical Group

Berkeley Heights, New Jersey, United States

Site Status

Comprehensive Clinical Research

Berlin, New Jersey, United States

Site Status

Lawrence OB-GYN Clinical Research, LLC

Lawrenceville, New Jersey, United States

Site Status

Delaware Valley Urology, LLC

Voorhees Township, New Jersey, United States

Site Status

Albuquerque Clinical Trials, Inc.

Albuquerque, New Mexico, United States

Site Status

SouthWest Clinical Research

Albuquerque, New Mexico, United States

Site Status

The Urological Institute of Northeastern New York

Albany, New York, United States

Site Status

Advanced Urology Centers of New York

Garden City, New York, United States

Site Status

Premier Medical Group of the Hudson Valley, PC

Kingston, New York, United States

Site Status

Manhattan Medical Research Practice PLLC

New York, New York, United States

Site Status

Premier Medical Group of the Hudson Valley, PC

Poughkeepsie, New York, United States

Site Status

Rochester Clinical Research, Inc.

Rochester, New York, United States

Site Status

Wake Research Associates, LLC

Raleigh, North Carolina, United States

Site Status

PMG Research of Wilmington

Wilmington, North Carolina, United States

Site Status

Lyndhurst Clinical Research

Winston-Salem, North Carolina, United States

Site Status

Radiant Research, Inc.

Cincinnati, Ohio, United States

Site Status

Rapid Medical Research, Inc.

Cleveland, Ohio, United States

Site Status

The Cleveland Clinic

Cleveland, Ohio, United States

Site Status

Radiant Research, Inc.

Columbus, Ohio, United States

Site Status

Physicians' Research, Inc.

Zanesville, Ohio, United States

Site Status

Urologic Consultants of SE PA

Bala-Cynwyd, Pennsylvania, United States

Site Status

Altoona Center for Clinical Research

Duncansville, Pennsylvania, United States

Site Status

Clinical Research of Philadelphia, LLC

Philadelphia, Pennsylvania, United States

Site Status

Advanced Clinical Concepts

West Reading, Pennsylvania, United States

Site Status

Greater Providence Clinical Research, LLC

Warwick, Rhode Island, United States

Site Status

Radiant Research, Inc.

Anderson, South Carolina, United States

Site Status

Fellows Research Alliance, Inc.

Bluffton, South Carolina, United States

Site Status

Medical Research South, LLC

Charleston, South Carolina, United States

Site Status

Coastal Carolina Research Center

Mt. Pleasant, South Carolina, United States

Site Status

Carolina Urologic Research Center

Myrtle Beach, South Carolina, United States

Site Status

Hillcrest Clinical Research, LLC

Simpsonville, South Carolina, United States

Site Status

Meridian Clinical Research

Dakota Dunes, South Dakota, United States

Site Status

The Jackson Clinic

Jackson, Tennessee, United States

Site Status

Advanced Therapeutics, Inc.

Johnson City, Tennessee, United States

Site Status

Tennesse Women's Care

Nashville, Tennessee, United States

Site Status

Tekton Research, Inc.

Austin, Texas, United States

Site Status

DiscoverResearch, Inc.

Bryan, Texas, United States

Site Status

Research Across America

Carrollton, Texas, United States

Site Status

Research Across America

Dallas, Texas, United States

Site Status

DCOL Center for Clinical Research

Longview, Texas, United States

Site Status

Quality Research Inc.

San Antonio, Texas, United States

Site Status

Clinical Trials of Texas, Inc.

San Antonio, Texas, United States

Site Status

Radiant Reseach, Inc.

San Antonio, Texas, United States

Site Status

Wasatch Clinical Research

Salt Lake City, Utah, United States

Site Status

The Group for Women

Norfolk, Virginia, United States

Site Status

Clinical Research Associates of Tidewater, Inc.

Norfolk, Virginia, United States

Site Status

Integrity Medical Research, LLC

Mountlake Terrace, Washington, United States

Site Status

Valley Women's Clinic

Renton, Washington, United States

Site Status

Seattle Women's Health, Research, Gynecology

Seattle, Washington, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TC-5214-23-CRD-003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

OnabotulinumtoxinA Bladder Injection Study
NCT03523091 TERMINATED PHASE4
A Safety Extension Study of DR-OXY-301
NCT00782769 COMPLETED PHASE3